Stock listing

DC4 Stock Price, News, Filings & Events — Dexcom, Inc.

Selected listing: DC4 · DUS · EUR · DE

This page tracks Dexcom, Inc.'s DC4:DUS listing on DUS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following DC4:DUS. DC4:DUS is the stock-level entry point for investors researching Dexcom, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Dexcom, Inc. (Ticker: DXCM) is a public company based in America, specializing in continuous glucose monitoring systems for diabetes management. With a market capitalization of approximately $27.6 billion, Dexcom is recognized for its innovative technology that helps improve the lives of individuals with diabetes. The company focuses on providing real-time glucose data to empower users in their health management.

DC4:DUSEURDEUpdated August 28, 2026
Dexcom, Inc. logo
Ticker
DC4:DUS
Asset type
Stock
Market cap
$34.27B
Sector
Health Technology
Industry
Medical Specialties
Exchange
DUS
Currency
EUR

Dexcom, Inc. DC4:DUS stock context

This page tracks Dexcom, Inc.'s DC4:DUS listing on DUS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following DC4:DUS. DC4:DUS is the stock-level entry point for investors researching Dexcom, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Dexcom, Inc. (Ticker: DXCM) is a public company based in America, specializing in continuous glucose monitoring systems for diabetes management. With a market capitalization of approximately $27.6 billion, Dexcom is recognized for its innovative technology that helps improve the lives of individuals with diabetes. The company focuses on providing real-time glucose data to empower users in their health management.

Latest news from Dexcom, Inc.

All Dexcom, Inc. news →

Dexcom, Inc. earnings calls

Research Dexcom, Inc.

Alternate listings